CompaniesInnovative Research

Innovative Research

active

Novi, MI, United States

Founded 1987

Website

About

Research Proteins, Kits, Antibodies

Areas of Focus

Categories

Non-PharmaceuticalAntibodyMidwest

Clinical Trials (51)

View all

Total Trials

As Lead Sponsor

As Collaborator

Total Enrollment

3,200

By Phase

PHASE2: 7PHASE4: 13PHASE1: 5PHASE1/PHASE2: 1NA: 9PHASE2/PHASE3: 1PHASE3: 6

By Status

COMPLETED: 36TERMINATED: 7ACTIVE_NOT_RECRUITING: 2RECRUITING: 2UNKNOWN: 2WITHDRAWN: 2

Clinical Trials Pipeline51 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Today

NCT00624676

Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris

Phase: N/A

Role: Collaborator

Start: Jan 31, 2006

Completion: Aug 31, 2006

NCT00353119

A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis

Phase: Phase 3

Role: Lead Sponsor

Start: Apr 30, 2006

Completion: Mar 31, 2007

NCT00629772

Safety and Efficacy of Infliximab in Palmoplantar Psoriasis

Phase: Phase 3

Role: Lead Sponsor

Start: Mar 31, 2007

Completion: Jul 31, 2009

NCT00927069

Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

Phase: Phase 3

Role: Lead Sponsor

Start: Mar 31, 2007

Completion: Dec 31, 2008

NCT00640393

Safety and Efficacy of Combining nbUVB to Etanercept in Patients

Phase: Phase 4

Role: Lead Sponsor

Start: Apr 30, 2008

Completion: Mar 31, 2010

NCT00931411

Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis

Phase: N/A

Role: Collaborator

Start: Jan 31, 2009

Completion: Jul 31, 2009

NCT00926952

Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion

Phase: Phase 3

Role: Lead Sponsor

Start: Jul 31, 2009

Completion: Jan 31, 2011

NCT00940862

Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

Phase: Phase 4

Role: Lead Sponsor

Start: Jul 31, 2009

Completion: Aug 31, 2011

NCT00967538

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Phase: Phase 4

Role: Lead Sponsor

Start: Sep 30, 2009

Completion: Jul 31, 2014

NCT00967538

NCT00974480

Comparison of Redermic, Rejuva-A and Combination of Both Redermic and Rejuva-A in Subjects With Signs of Aging

Phase: N/A

Role: Collaborator

Start: Sep 30, 2009

Completion: Jul 31, 2010

NCT01091051

Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis

Phase: Phase 3

Role: Lead Sponsor

Start: Mar 31, 2010

Completion: Nov 30, 2011

NCT01098019

Treatment of Notalgia Paresthetica With Xeomin

Phase: Phase 3

Role: Lead Sponsor

Start: Apr 30, 2010

Completion: Feb 29, 2012

NCT01139918

Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis

Phase: N/A

Role: Lead Sponsor

Start: Jun 30, 2010

Completion: Jul 31, 2014

NCT01139918

NCT01181570

Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea

Phase: Phase 4

Role: Lead Sponsor

Start: Sep 30, 2010

Completion: Sep 30, 2011

NCT01545284

Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis

Phase: Phase 2/3

Role: Lead Sponsor

Start: Mar 31, 2012

Completion: Jan 31, 2014

NCT01556672

Adalimumab-psoriasis and Small Bowel Lesions

Phase: Phase 4

Role: Lead Sponsor

Start: Apr 30, 2012

Completion: Apr 30, 2016

NCT01556672

NCT01577628

Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis

Phase: N/A

Role: Collaborator

Start: Jun 30, 2012

Completion: Feb 28, 2013

NCT01640028

Exploratory Study of Intra and Inter-subject Variability in Sebum Excretion Rate

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2012

Completion: Dec 31, 2012

NCT01722214

Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Phase: Phase 4

Role: Lead Sponsor

Start: Nov 30, 2012

Completion: Jan 31, 2016

NCT01739140

Yoga for Chronic Low Back Pain and Its Mechanism of Action (YoMA)

Phase: N/A

Role: Collaborator

Start: Dec 31, 2012

Completion: Dec 31, 2015

NCT01927679

Vitamin E Prevention of Visible Light Pigmentation

Phase: N/A

Role: Lead Sponsor

Start: Aug 31, 2013

Completion: Nov 30, 2013

NCT01978483

Effect of RANKL Inhibition on UV-induced Immunosuppression

Phase: Phase 1

Role: Lead Sponsor

Start: Nov 30, 2013

Completion: Jun 30, 2014

NCT02078297

IL-17 Role in Variants of Psoriasis

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2014

Completion: Mar 31, 2015

NCT02109289

Etanercept in Rheumatoid Arthritis and Vascular Inflammation

Phase: Phase 4

Role: Lead Sponsor

Start: Apr 30, 2014

Completion: Nov 30, 2016

NCT02270411

Inflammatory Cells From Various Pathologies

Phase: N/A

Role: Lead Sponsor

Start: May 31, 2014

Completion: Dec 31, 2023

NCT02270411

NCT02305953

Cytokines and Vascular Inflammation in Psoriasis

Phase: N/A

Role: Lead Sponsor

Start: Oct 31, 2014

Completion: Oct 31, 2014

NCT02324972

Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis

Phase: Phase 2

Role: Collaborator

Start: Dec 31, 2014

Completion: Dec 31, 2015

NCT02400749

Apremilast in Palmo-Plantar Psoriasis

Phase: Phase 4

Role: Lead Sponsor

Start: May 31, 2015

Completion: Nov 30, 2016

NCT02408159

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Phase: Phase 4

Role: Lead Sponsor

Start: Jun 30, 2016

Completion: Mar 31, 2017

NCT02926807

Trial on Vascular Inflammation in Atopic Dermatitis

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2017

Completion: Nov 30, 2018

NCT03108079

Bladder Morphology Using 2 Different Catheter Designs

Phase: N/A

Role: Collaborator

Start: Apr 30, 2017

Completion: Jun 30, 2017

NCT04537468

Development of a Method to Measure mRNA Levels in Skin Samples

Phase: N/A

Role: Lead Sponsor

Start: May 11, 2017

Completion: Oct 2, 2019

NCT03201978

A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

Phase: Phase 1

Role: Collaborator

Start: Dec 14, 2017

Completion: May 15, 2018

NCT03625219

Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers

Phase: N/A

Role: Lead Sponsor

Start: Jul 26, 2018

Completion: Jun 9, 2020

NCT03630939

A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis

Phase: Phase 1/2

Role: Collaborator

Start: Aug 9, 2018

Completion: Jun 12, 2019

NCT03795402

Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling

Phase: N/A

Role: Collaborator

Start: Mar 15, 2019

Completion: Dec 6, 2019

NCT03971643

Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum

Phase: Phase 2

Role: Collaborator

Start: May 16, 2019

Completion: Jan 3, 2022

NCT03868098

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

Phase: Phase 4

Role: Lead Sponsor

Start: May 21, 2019

Completion: Nov 25, 2020

NCT04706962

TH1902 in Patients With Advanced Solid Tumors

Phase: Phase 1

Role: Collaborator

Start: Mar 4, 2021

Completion: Jan 31, 2026

NCT04706962

NCT04999839

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Phase: Phase 2

Role: Collaborator

Start: Aug 11, 2021

Completion: Sep 12, 2022

NCT05034822

Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Phase: Phase 1

Role: Collaborator

Start: Dec 16, 2021

Completion: Aug 7, 2023

NCT05382819

A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis

Phase: Phase 1

Role: Collaborator

Start: May 16, 2022

Completion: Aug 11, 2023

NCT05602207

Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab

Phase: Phase 4

Role: Lead Sponsor

Start: Nov 25, 2022

Completion: Jan 9, 2025

NCT05491447

A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis

Phase: Phase 2

Role: Collaborator

Start: Jan 8, 2023

Completion: Apr 15, 2024

NCT05499416

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

Phase: Phase 4

Role: Lead Sponsor

Start: Jan 31, 2023

Completion: Apr 30, 2024

NCT05844618

Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis

Phase: Phase 4

Role: Lead Sponsor

Start: May 9, 2023

Completion: Mar 24, 2025

NCT05835843

Study to Assess the Reliability of PASI Scoring Using Digital-Based Images

Phase: N/A

Role: Lead Sponsor

Start: Jun 2, 2023

Completion: Sep 5, 2025

NCT05994976

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Phase: N/A

Role: Lead Sponsor

Start: Oct 17, 2023

Completion: Aug 31, 2028

NCT05994976

NCT06101823

Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis

Phase: Phase 2

Role: Collaborator

Start: Oct 25, 2023

Completion: Jun 30, 2025

NCT06261021

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

Phase: Phase 2

Role: Lead Sponsor

Start: Apr 19, 2024

Completion: Feb 28, 2026

NCT06283550

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Phase: Phase 2

Role: Lead Sponsor

Start: May 31, 2024

Completion: Dec 31, 2025

Hover over trial bars to see details

Recent Trials

NCT06283550Lead Sponsor

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

PHASE2Active, not recruiting

84 participants

Started: May 31, 2024 · Completed: Dec 31, 2025

NCT06261021Lead Sponsor

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

PHASE2Recruiting

20 participants

Started: Apr 19, 2024 · Completed: Feb 28, 2026

NCT06101823Collaborator

Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis

PHASE2Unknown

48 participants

Started: Oct 25, 2023 · Completed: Jun 30, 2025

NCT05994976Lead Sponsor

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

N/ARecruiting

500 participants

Started: Oct 17, 2023 · Completed: Aug 31, 2028

NCT05835843Lead Sponsor

Study to Assess the Reliability of PASI Scoring Using Digital-Based Images

N/ACompleted

34 participants

Started: Jun 2, 2023 · Completed: Sep 5, 2025

View all 51 trials →

Locations (1)

Headquarters

Novi, MI, United States

Map

Loading map...